Mia's Feed
Medical News & Research

Deep Tissue Cancer Treatment with Cold Plasma Technology

Deep Tissue Cancer Treatment with Cold Plasma Technology

Share this article

Innovative research shows that cold plasma can penetrate deep into tissue layers to target and destroy cancer cells, offering new hope for advanced cancer therapies.

2 min read

Researchers from the Leibniz Institute for Plasma Science and Technology (INP), in collaboration with Greifswald University Hospital and University Medical Center Rostock, have demonstrated that cold plasma can effectively target and destroy tumor cells located deep within tissues. This innovative approach utilizes cold plasma, an ionized gas rich in reactive molecules, to penetrate tissue layers and impact cancer cells that are otherwise difficult to reach with conventional therapies.

A significant breakthrough was made by developing advanced tissue models composed of hydrogels, which mimic real tumor tissue. This allowed scientists to observe how specific plasma components, particularly short-lived reactive oxygen and nitrogen species like peroxynitrite, infiltrate tissue and influence tumor cells. Notably, peroxynitrite was able to penetrate several millimeters into tissue, effectively reaching target cells, while hydrogen peroxide, previously thought to be the main active molecule, showed minimal effect when isolated.

The research also explored the potential of plasma in post-surgical cancer treatments. By applying plasma to residual tumor cells at the margins of an artificial wound, the scientists observed strong anticancer effects, especially on cells that had migrated into surrounding tissues. These findings could contribute to reducing cancer relapse rates following surgery.

The study utilized the FDA-approved plasma jet device, 'kINPen,' paving the way for long-term, minimally invasive cancer therapies. Understanding which molecules are responsible for plasma's effects enables more precise application of plasma devices tailored to specific cancer types. This advancement marks a crucial step toward integrating plasma medicine into routine clinical practice, offering a promising alternative treatment for deep-seated tumors.

For more information, the full study is published in Trends in Biotechnology: Lea Miebach et al, Gas plasma technology mediates deep tissue and anticancer events independently of hydrogen peroxide, 2025. [DOI: 10.1016/j.tibtech.2025.07.004]. Source: https://medicalxpress.com/news/2025-08-cold-plasma-penetrates-deep-tissue.html

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

How Cell Metabolic Communication Hampers Anti-Tumor Immune Responses

New research reveals how cancer cells manipulate neighboring cells’ metabolism, promoting immune suppression and tumor growth, opening potential pathways for improved cancer therapies.

Emerging Role of Immunotherapy for Organ Transplant Patients with Advanced Cancer

New research reveals that carefully managed immunotherapy can benefit organ transplant recipients with advanced cancer, offering promising survival outcomes despite some rejection risks.

Innovative Blood Test Accelerates Diagnosis of Rare Genetic Diseases in Children

A new blood test developed by researchers offers a rapid, less invasive way to diagnose rare genetic diseases in children, potentially transforming pediatric genetic diagnostics with faster results and broader detection capabilities.

The Role of Fetal Autopsies in Preventing Stillbirths and Addressing Society’s Blame

Fetal autopsies are essential for understanding and preventing stillbirths but are underutilized and wrongly used to blame mothers, especially in criminal cases. Improving access and expertise is key to better outcomes.